Evaluate Risks Before Prescribing a Flozin

November 2018

New safety concerns will raise questions about when to use an SGLT2 inhibitor (Invokana, etc) for type 2 diabetes.

Flozins are in the spotlight lately...since some may have cardiovascular and renal benefits.

But we know flozins have risks...yeast infections, UTIs, hypotension, acute kidney injury, rare ketoacidosis or fractures, etc.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote